ArticleMedScience2026

Hepatitis B virus infection or reactivation and HBV-related liver dysfunction in patients with inflammatory bowel disease receiving infliximab: a nationwide real-world study.

Rongbei Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.